TY  - JOUR
AU  - Romero-Laorden, N
AU  - Piñeiro-Yañez, E
AU  - Gutierrez-Pecharroman, A
AU  - Pacheco, M I
AU  - Calvo, E
AU  - Al-Shahrour, F
AU  - Castro, E
AU  - Olmos, D
PY  - 2017
DO  - 10.1093/annonc/mdx067
UR  - http://hdl.handle.net/10668/11146
T2  - Annals of oncology : official journal of the European Society for Medical Oncology
LA  - en
KW  - Aged
KW  - BRCA2 Protein
KW  - Benzimidazoles
KW  - Genes, BRCA2
KW  - Germ-Line Mutation
KW  - Humans
KW  - Loss of Heterozygosity
KW  - Male
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Prostatic Neoplasms, Castration-Resistant
TI  - Somatic BRCA2 bi-allelic loss in the primary prostate cancer was associated to objective response to PARPi in a sporadic CRPC patient.
TY  - research article
VL  - 28
ER  -